NCT03614208

Brief Summary

Systemic sclerosis (SSc) is an uncommon chronic rheumatic disease with an unknown cause and unpredictable course. The inability, in addition to easy fatigability, starts a vicious circle that leads to a fast deterioration of physical conditions that cause a reduction of aerobic exercise capacity and, consequently, of health-related quality of life (HRQoL). Aerobic exercise has already been shown to be safe and effective in improving exercise capacity and HRQoL of patients with chronic cardiovascular and pulmonary diseases. However, few studies have evaluated the role of specific exercise programs on the muscular impairment in SSc. Nevertheless, the results obtained in preliminary reports are promising, and, for these reasons, the management of muscular impairment in SSc could include an appropriate rehabilitation program besides pharmaceutical and surgical treatments. The primary aim of this study will be to evaluate the effect of an individualized exercise program performed at home on aerobic capacity evaluated by 6 minutes walking test. Secondary aims will be to evaluate: 1- VO2max, measured by cardiopulmonary test; 2- the effect of the same program on the muscular strength of upper and lower limbs; 3- the efficacy of a self-administered stretching program for finger joint motion. Secondary aims will be also 1-to ascertain whether a comprehensive exercise program may affect, besides physical function, HRQoL; 2- and to evaluate the adherence during two periods of three months, one whit and one without supervision and reinforcement by a phone call. All the patients with a diagnosis of SSc, according to the criteria of American College of Rheumatology (ACR), who attended the Rheumatologic outpatient clinic of our institution will be evaluated in order to participate in the rehabilitation program. The pneumological examination and two days of screening and testing will take place at the outpatient's clinic of Respiratory Medicine and Sport of our institution.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
33

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Feb 2017

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2017

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2018

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

July 26, 2018

Completed
8 days until next milestone

First Posted

Study publicly available on registry

August 3, 2018

Completed
Last Updated

August 3, 2018

Status Verified

August 1, 2018

Enrollment Period

1.1 years

First QC Date

July 26, 2018

Last Update Submit

August 2, 2018

Conditions

Keywords

Systemic sclerosisHome based rehabilitationQuality of lifeHand mobilityExercise capacity

Outcome Measures

Primary Outcomes (1)

  • Six minute walking test

    Evaluate aerobic capacity

    Up to six months

Secondary Outcomes (9)

  • Maximum oxygen consumption (VO2max)

    Up to six months

  • Handgrip strength

    Up to six months

  • Muscular strength of upper limbs

    Up to six months

  • One repetition maximum (1-RM) of biceps strength

    Up to six months

  • Muscular strength of lower limbs

    Up to six months

  • +4 more secondary outcomes

Study Arms (2)

Home-care rehabilitation group (HCRG)

EXPERIMENTAL

The home-based exercise program consists of aerobic exercise on a stationary bike, muscular endurance training of the upper limb and stretching exercises for finger joint motion. The exercise on the stationary bike and muscular endurance training will be performed on alternate days, three times a week. For finger stretching the patients will be directed to perform it every day, both in the morning and in the evening. During the rehabilitation period, the patients will report each day on a diary for each type of exercise. They received a phone call monthly, only for the first 3 months, to encourage them about the adherence and investigate any problems with the exercise program.

Behavioral: Home-care rehabilitation group (HCRG)

Control group

NO INTERVENTION

Control group was encouraged to perform the generic aerobic physical activity at the baseline. Also, they received a monthly phone call, only for the first 3 months, to encourage them about the importance of doing aerobic exercise.

Interventions

The exercise program consists of aerobic exercise on a stationary bike, muscular endurance training of the upper limb and stretching exercises for finger joint motion. The exercise on the stationary bike and muscular endurance training will be performed on alternate days, three times a week.

Also known as: Experimental group
Home-care rehabilitation group (HCRG)

Eligibility Criteria

Age18 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • diagnosis of SSc according to the criteria of ACR
  • no hospitalizations in the previous 3 months
  • no change in anti-rheumatic treatment in the previous 3 months
  • signed informed consent

You may not qualify if:

  • heart failure staging in classes III or IV of New York Heart Association (NYHA)
  • pulmonary hypertension, defined by echocardiogram as a right ventricular systolic pressure ≥ 45mmHg
  • vital capacity (VC) ≤ 50% or diffusion lung capacity of carbon monoxide (DLCO) ≤ 30% of predicted values.
  • renal failure defined as a calculated glomerular filtration rate (GFR) \< 30ml/min, in agreement with the staging of International Federation of National Kidney Foundations
  • inability to perform the rehabilitation program due to skeletal-muscle impairments or other illnesses
  • pregnancy or planned pregnancy in the next 6 months
  • psychiatric disorders that prevent collaboration and adherence at the rehabilitation the program, including drug abuse
  • involvement in ongoing aerobic or anaerobic exercise programs
  • Drop out criteria:
  • the demonstration of ischemic heart disease after cardiopulmonary exercise testing performed at baseline
  • need to change the dosage or interruption of prostanoids used in the treatment of SSc during the 6 months of the treatment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Azienda Ospedaliera, SSO respiratory pathophysiology Unit, Verona

Verona, Italy/Verona, 37134, Italy

Location

MeSH Terms

Conditions

Scleroderma, Systemic

Condition Hierarchy (Ancestors)

Connective Tissue DiseasesSkin and Connective Tissue DiseasesSkin Diseases

Study Officials

  • Marcello Ferrari, Professor

    Universita di Verona

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Single blind RCT with two parallel group
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

July 26, 2018

First Posted

August 3, 2018

Study Start

February 1, 2017

Primary Completion

March 1, 2018

Study Completion

March 1, 2018

Last Updated

August 3, 2018

Record last verified: 2018-08

Locations